Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase for Residual Dupuytren's Disease
NCT00004409Phase 2
Key facts
- Status
- Completed
- Start
- Aug 1995
- Countries
- 1
- Sponsor
- State University of New York
- Modality
- Therapeutic Enzymes
- Conditions
- Dupuytren's contracture
01
Overview
Phase 2, randomised, single-blind trial in Dupuytren's contracture comparing Collagenase with Placebo (2 arms). Started Aug 1995; status: completed.
02
Design
2 arms- Study design
- RandomizedSingle-blind
Collagenase
Single dose of collagenase injection
Placebo
Single dose of placebo injection
03
Who it enrols
Patients with residual Dupuytren's disease, fixed flexion deformity of 20-30 degrees, positive table top test, and no history of significant illness or allergy to collagenase.
Beyond the preview
Go deeper on NCT00004409.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004409.